(19)
(11) EP 3 829 714 A1

(12)

(43) Date of publication:
09.06.2021 Bulletin 2021/23

(21) Application number: 19758812.2

(22) Date of filing: 01.08.2019
(51) International Patent Classification (IPC): 
A61P 3/06(2006.01)
A61K 36/29(2006.01)
A61K 45/06(2006.01)
A61K 36/28(2006.01)
A61K 36/67(2006.01)
(86) International application number:
PCT/IB2019/056566
(87) International publication number:
WO 2020/026186 (06.02.2020 Gazette 2020/06)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 01.08.2018 IT 201800007746

(71) Applicant: Pharmanutrition R&D S.r.l.
20143 Milano MI (IT)

(72) Inventor:
  • RISSA, Mauro
    20143 Milano MI (IT)

(74) Representative: Perani & Partners S.p.A. 
Piazza Armando Diaz, 7
20123 Milano
20123 Milano (IT)

   


(54) ORAL NUTRACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF METABOLIC SYNDROME